Introduction

For patients diagnosed with EGFR-mutated non-small cell lung cancer (NSCLC), timely access to prescribed medicines such as Osimertinib can make a significant difference in treatment continuity.

However, access to Osimertinib varies widely across countries. Some nations experience delayed product launches, medicine shortages, or regulatory limitations that make obtaining treatment challenging.

India has become one of the world’s leading pharmaceutical manufacturing and export hubs, supplying high-quality medicines to healthcare providers and patients worldwide.

Through regulated patient access pathways, international patients may be able to obtain prescribed oncology medicines from experienced exporters.

At CBMeds, a division of Curiance Biotech, we help facilitate responsible international access to oncology medicines while maintaining regulatory compliance and patient-focused support.

Why India Is a Global Pharmaceutical Hub

India is often referred to as the “Pharmacy of the World.”

The country supplies medicines to more than 200 countries and is recognized for:

• WHO-GMP manufacturing facilities
• Skilled pharmaceutical workforce
• Strong export infrastructure
• Competitive manufacturing capabilities
• Extensive oncology medicine production

Indian pharmaceutical companies play an important role in improving global access to life-saving medicines.

What Is Osimertinib?

Osimertinib is a third-generation EGFR tyrosine kinase inhibitor (TKI) used to treat certain patients with EGFR-mutated NSCLC.

It is commonly prescribed for:

• First-line treatment of EGFR-mutated NSCLC
• Patients with EGFR Exon 19 deletion
• Patients with EGFR L858R mutation
• Certain patients with brain metastases
• Selected patients with T790M-positive disease after earlier EGFR therapy

Treatment decisions should always be made by a qualified oncologist.

Why International Patients Order From India

Patients may seek medicine access from India for several reasons:

• Local medicine shortages
• Delayed regulatory approvals
• Limited distribution
• Smaller pharmaceutical markets
• Physician recommendation
• Need for uninterrupted treatment

International medicine access must always comply with the regulations of both the exporting and importing countries.

How International Orders Work

Although regulations differ by country, the process generally follows several important steps.

Step 1: Oncologist Prescription

The patient’s treating oncologist prescribes Osimertinib based on their diagnosis and molecular testing results.

Step 2: Documentation Review

Required documents may include:

• Prescription
• Patient identification
• Medical diagnosis
• Import documentation (where required)

The documentation is reviewed before processing begins.

Step 3: Regulatory Compliance

The export team verifies that the shipment complies with applicable regulations in both India and the destination country.

Compliance helps ensure safe and legal medicine supply.

Step 4: Quality-Assured Sourcing

Medicines are sourced through verified pharmaceutical supply chains following recognized quality standards.

Quality assurance includes:

• Proper storage
• Batch traceability
• Documentation support
• Secure packaging

Step 5: International Shipping

Once documentation is approved, medicines are dispatched using international logistics partners.

Tracking information is typically provided throughout the shipping process.

Typical Delivery Timeline

Delivery time depends on:

• Destination country
• Customs clearance
• Local regulations
• Documentation completeness
• Courier services

In many cases, deliveries are completed within 15–20 working days after documentation approval.

Why Documentation Is Important

International pharmaceutical exports require careful documentation.

Proper documentation helps:

• Ensure regulatory compliance
• Prevent customs delays
• Protect patient safety
• Maintain medicine traceability

Patients should never attempt to import prescription medicines without appropriate medical documentation.

Quality and Safety

When obtaining medicines internationally, patients should choose experienced suppliers that prioritize:

• Quality assurance
• Regulatory compliance
• Verified sourcing
• Secure international logistics
• Responsive customer support

Patient safety should always remain the highest priority.

How CBMeds Supports International Patients

CBMeds, a division of Curiance Biotech, supports eligible patients and healthcare professionals in accessing prescribed oncology medicines through established regulatory pathways.

Our services include:

• International patient support
• Documentation guidance
• Regulatory assistance
• Quality-assured sourcing
• Worldwide shipping
• Healthcare professional coordination

We currently support patients in 175+ countries, subject to local regulations and applicable medicine access frameworks.

Frequently Asked Questions

Can anyone order Osimertinib internationally?

No.

A valid prescription from a licensed physician is generally required.

Is international medicine export legal?

Yes, when carried out under applicable regulations and patient access frameworks.

Requirements vary by country.

How long does delivery take?

Delivery timelines depend on customs procedures and destination country regulations.

Many shipments are completed within 15–20 working days after documentation approval.

Does CBMeds provide medical advice?

No.

Treatment decisions should always be made by the patient’s treating oncologist.

CBMeds supports medicine access—not medical diagnosis or treatment recommendations.

Why choose an experienced exporter?

Experienced exporters understand regulatory documentation, quality assurance, and international logistics, helping reduce delays and ensure compliance.

Final Thoughts

Access to prescribed cancer medicines should not be limited by geography.

As global healthcare becomes increasingly connected, regulated international medicine access programs help eligible patients continue treatment even when medicines are unavailable locally.

Understanding the export process, preparing documentation early, and working with experienced suppliers can help ensure a smoother experience.

At CBMeds, a division of Curiance Biotech, we remain committed to supporting patients, hospitals, and healthcare professionals through responsible medicine access, regulatory expertise, and quality-focused service.

Medical Disclaimer

This article is intended for educational purposes only and should not replace professional medical advice. Patients should always consult their treating oncologist regarding diagnosis, treatment, and medicine access.